Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 19, 2008

ArunA Obtains Commercialization Rights to Univ. of Georgia's Human Mesenchymal Stem Cells

  • ArunA Biomedical gained a license that allows it to commercialize human mesenchymal cells (hMSC™) developed at the University of Georgia Research Foundation. These hMSCs are derived from human embryonic stem cells.

    ArunA reports that it will offer the academic and industrial research communities access to a highly uniform population of human mesenchymal cells grown as adherent monolayer cultures in multiple turn-key kit formats.

    “We are targeting an early first quarter 2009 launch of ArunA's first hMSC kit,”  says William Sharp, president and CEO.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »